The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABTU.L Regulatory News (ABTU)

  • There is currently no data for ABTU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FDA's Import Alert for AquAdvantage® Salmon

29 Jan 2016 17:18

RNS Number : 5294N
Aqua Bounty Technologies, Inc.
29 January 2016
 

FOR IMMEDIATE RELEASE

29 January 2016

 

AquaBounty Technologies, Inc.

("AquaBounty" or "the Company")

 

FDA's Import Alert for AquAdvantage® Salmon

 

MAYNARD, Massachusetts, 29 January 2016 - AquaBounty Technologies, Inc. (AIM: ABTU; OTC: AQBT), a biotechnology company focused on enhancing productivity in aquaculture, and a majority-owned subsidiary of Intrexon Corporation (NYSE: XON), notes that the U.S. Food and Drug Administration (FDA) has today issued an Import Alert on the Company's AquAdvantage® Salmon. In making the announcement, the FDA stated that the temporary hold is being implemented to comply with language in the 2016 Omnibus Appropriations Act. The particular language directed the FDA to issue final guidance for GMO labeling of AquAdvantage, despite the absence of any GMO labeling requirement in the FDA's recent New Animal Drug Application approval. Current FDA policy does not require labeling for method of production if there is no material difference compared to traditional foods, and FDA found AquAdvantage as safe to consume as traditional farmed Atlantic salmon.

Ronald L. Stotish, Ph.D., Chief Executive Officer of AquaBounty, stated, "The decision has no impact on AquaBounty's operations as we are not currently importing our salmon into the United States. The FDA is working to complete the guidelines required by the Appropriations Act."

AquAdvantage Salmon was approved for production and human consumption by the FDA on November 19, 2015 after a thorough and rigorous scientific review over a period of 20 years. In its announcement, the FDA stated that AquAdvantage Salmon is as safe and nutritious to eat as any non-genetically engineered Atlantic salmon.

AquAdvantage Salmon will be farmed in land-based recirculating aquaculture systems (RAS) that recycle over 95% of the culture water resulting in minimal impact on the environment. Its greater efficiency in converting feed to edible protein reduces the pressure on wild fish harvested for fish meal and fish oil. AquAdvantage Salmon is an excellent source of healthy omega-3 fatty acids that have been shown to benefit human health.

The Company is committed to providing AquAdvantage Salmon to consumers looking for a more environmentally responsible seafood choice.

###

For further information, please contact:

 

AquaBounty Technologies +1 978 648 6048

David Frank, Chief Financial Officer

 

Stifel Nicolaus Europe Limited +44 (0)20 7710 7600

Stewart Wallace

 

Luther Pendragon +44 (0)20 7618 9100

Harry Chathli, Claire Norbury

 

About AquaBounty Technologies

AquaBounty Technologies is a publicly traded company whose largest shareholder is Intrexon Corporation (NYSE: XON). Intrexon is a synthetic biology company with diverse interests in medicine, food and agriculture, and fuels and the environment. AquaBounty Technologies is an aquaculture company focused on improving productivity in commercial aquaculture, a $144 billion industry and the fastest growing segment of the worldwide food industry. The company's objective is the application of biotechnology to ensure the availability of high quality seafood to meet global consumer demand. The company is developing products to address critical production constraints in the most popular farmed species, focusing initially on salmon, trout and tilapia. Its AquAdvantage® fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development.

 

Safe Harbor Statement

Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEIFWUFMSEFF
Date   Source Headline
30th May 20172:30 pmRNSConfirmation of AIM cancellation date
24th May 20177:00 amRNSResult of AGM
9th May 20177:00 amRNSResults for the quarter ended March 31, 2017
24th Apr 20177:00 amRNSIssuance of Common Shares and Options
20th Apr 20177:00 amRNSPublication of 2016 Annual Report and Accounts
7th Apr 20171:45 pmRNSIntended Delisting
16th Mar 20177:00 amRNSFull Year Results
26th Jan 20177:00 amRNSHoldings Announcement
19th Jan 20177:00 amRNSCompletion of NASDAQ Listing and Fundraising
5th Jan 20178:10 amRNSCompletion of Reverse Share Split
4th Jan 201711:07 amRNSReverse Share Split Further Update
29th Dec 20165:16 pmRNSReverse Share Split Update
21st Dec 20167:00 amRNSDebt Conversion Update
19th Dec 20167:00 amRNSReverse Share Split and Debt Conversion Update
28th Nov 20162:00 pmRNSResult of Special Meeting
15th Nov 20167:00 amRNSSpecial Meeting
7th Nov 201611:41 amRNSFiling of Form 10 and Equity Subscription
24th Oct 20162:47 pmRNSUpdate on Legal Actions
12th Oct 20167:00 amRNSWithdrawal of Form 10
28th Sep 20167:00 amRNSExercise of Options
12th Aug 20167:00 amRNSChange of Registered Address
28th Jul 20167:00 amRNSInterim Results
8th Jul 20166:03 pmRNSExpansion in Canada
20th May 20167:00 amRNSCanadian authorities approve AquAdvantage Salmon
26th Apr 20165:35 pmRNSResult of AGM
21st Mar 20164:56 pmRNSPublication of Annual Report and Accounts 2015
4th Mar 20167:00 amRNSIssuance of Common Shares and Options
29th Feb 20167:00 amRNSPreliminary Results and Notification of AGM
24th Feb 20167:00 amRNSDebt Financing
29th Jan 20165:18 pmRNSFDA's Import Alert for AquAdvantage® Salmon
14th Jan 20164:40 pmRNSSecond Price Monitoring Extn
14th Jan 20164:35 pmRNSPrice Monitoring Extension
24th Dec 20157:00 amRNSFederal Court of Canada Ruling
24th Nov 20154:40 pmRNSSecond Price Monitoring Extn
24th Nov 20154:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.